









Markets
/
Stocks
/
nasdaq-drts
/

Alpha Tau Medical Ltd

DRTS

3.810USD

-0.030-0.78%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

268.15MMarket Cap

LossP/E TTM



Alpha Tau Medical Ltd

3.810

-0.030-0.78%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

137 / 207

Overall Ranking

374 / 4723

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

8.500

Target Price

+120.20%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.

Undervalued

The company’s latest PE is -7.95, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 29.36M shares, increasing 32.33% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 29.40K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.42.

Financial Health

Currency: USD Updated：2025-09-17

There is no financial score for this company; the Healthcare Equipment & Supplies industry's average is 7.32.

Score

Industry at a Glance

Previous score

0.00

Change



Financials



Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings



Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency



Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential



Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns



Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -7.95, which is -23.25% below the recent high of -6.10 and 14.98% above the recent low of -6.76.

Score

Industry at a Glance

Previous score

2.00

Change

-0.8

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 137/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

The company’s current earnings forecast score is 9.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Alpha Tau Medical Ltd is 8.50, with a high of 12.00 and a low of 5.00.

Score

Industry at a Glance

Previous score

9.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

8.500

Target Price

+121.35%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Alpha Tau Medical Ltd

DRTS

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 8.66, which is higher than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 4.21 and the support level at 3.25, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.89

Change

-0.23

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.030

Buy

RSI(14)

64.176

Neutral

STOCH(KDJ)(9,3,3)

68.074

Neutral

ATR(14)

0.183

Low Volatility

CCI(14)

64.304

Neutral

Williams %R

22.222

Buy

TRIX(12,20)

0.812

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

3.834

Sell

MA10

3.794

Buy

MA20

3.571

Buy

MA50

3.304

Buy

MA100

3.129

Buy

MA200

3.072

Buy

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 34.67%, representing a quarter-over-quarter increase of 44.63%. The largest institutional shareholder is James Simons, holding a total of 29.40K shares, representing 0.03% of shares outstanding, with 40.65% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Oramed Pharmaceuticals Inc

14.11M

Sofer (Uzi)

11.52M

Avruch (Michael)

1.55M

+0.17%

Hightower Advisors, LLC

230.70K

Keisari (Yona)

504.27K

+0.16%

HoyleCohen, LLC

269.09K

Kovitz Investment Group Partners, LLC

226.32K

+601.44%

Levin Capital Strategies, L.P.

222.51K

-29.25%

Milch (David Mark)

88.74K

-2.20%

Gat (Amnon)

68.47K

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 4.10, which is higher than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.02. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.